Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.

Ketil Lunde,Svein Solheim,Kolbjørn Forfang,Harald Arnesen,Lorentz Brinch,Reidar Bjørnerheim,Asgrimur Ragnarsson,Torstein Egeland,Knut Endresen,A. Ilebekk,Arild Mangschau,Svend Aakhus

Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up.

2008

Ketil Lunde
Svein Solheim
Kolbjørn Forfang
Harald Arnesen
Lorentz Brinch
Reidar Bjørnerheim
Asgrimur Ragnarsson
Torstein Egeland
Knut Endresen
A. Ilebekk
Arild Mangschau
Svend Aakhus

To the Editor: Intracoronary injection of bone marrow cells (BMC) has been introduced for improvement of left ventricular (LV) function after acute myocardial infarction (AMI). In the randomized ASTAMI (Autologous Stem cell Transplantation in Acute Myocardial Infarction) study, BMC treatment did not

Keywords:

Bone marrow
Percutaneous coronary intervention
Diabetes mellitus
Internal medicine
Myocardial infarction
Cardiology
Anterior myocardial infarction
Autologous stem-cell transplantation
Medicine
ventricular function

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations